Clinical Trials Logo

Clinical Trial Summary

A clinical trial to evaluate the safety and effectiveness of the Aurora Xi Plasmapheresis System with a new plasma collection volume nomogram.


Clinical Trial Description

A controlled, prospective, randomized, multicenter, IDE clinical trial to evaluate the safety and effectiveness of a new plasma collection volume nomogram on the Aurora Xi Plasmapheresis System (test arm) as compared to the currently marketed Optimized Nomogram on the Aurora Xi Plasmapheresis System (control arm). The new plasma collection volume nomogram will provide a more individualized approach to determining the volume of plasma collected from each donor. The trial will be conducted at a minimum of 3 plasma collection centers. Subjects will be randomized into the test and control arms. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06122935
Study type Interventional
Source Fenwal, Inc.
Contact Jason Friedmann
Phone 847-550-5620
Email jason.friedmann@fresenius-kabi.com
Status Not yet recruiting
Phase N/A
Start date November 14, 2023
Completion date August 14, 2024

See also
  Status Clinical Trial Phase
Completed NCT04320823 - IMPACT (Improving Plasma Collection) Clinical Trial N/A